Is PT-141 FDA approved?

Yes, under the brand name Vyleesi, specifically for hypoactive sexual desire disorder in premenopausal women, based on trials covering more than 1,200 participants. That approval is limited to that one population and indication; use outside it, including in men, is off label or through the unapproved research chemical market.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of sexual health and hormone peptides. PT-141, melanotan, oxytocin, gonadorelin, and kisspeptin-10.